JNJ-87562761
- Generic Name
- JNJ-87562761
A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 80
- Registration Number
- NCT06604715
- Locations
- 🇪🇸
Hosp. Univ. Germans Trias I Pujol, Badalona, Spain
🇪🇸Hosp Clinic de Barcelona, Barcelona, Spain
🇪🇸Hosp Clinico Univ de Salamanca, Salamanca, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath